Inclisiran The First SiRNA Therapeutic

(7:1econd)

siRNA pCSK9 therapeutics Clinical perspectives | Professor Steve Nicholls

(3:41)

What Is siRNA Therapy for High Cholesterol? | GoodRx

(2:5)

siRNA therapeutics: next story for PCSK9?

(2:55)

Hot Topic siRNA and PCSK9 | Dr Peter Lansberg

(1:46)

Inhibition of PCSK9 Synthesis Via RNA Interference

(5:23)

Targeting LDL Cholesterol with a Small Interfering RNA

(2:48)

What is PCSK9 and how PCSK9 inhibitors work? (Mechanism of action)

(5:41)

Inclisiran - MoA and Side effects | SiRNA therapy to treat Hypercholestrolemia | PCSK9 Inhibitor

(3:49)

Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome?

(23:18)

Pushing the Envelope with PCSK9-Twenty Years of Progress

(58:49)

What is siRNA Technology?

(1:51)

Diagnosing and Treating Hyperlipidemia: Recent Evidence and the Role of PCSK9-targeted Therapies

(53:13)

Inclisiran Mechanism of Action (RNA Interference) #cholesterol #rna #cardiology #biology #science

(59)

Treatment Strategies for Drug-Resistant Hyperlipidemia, Part 2

(7:46)

Lipid Management: The Ins and Outs of Inclisiran

(10:3)

QB3 Webinar: Vasant Jadhav, Alnylam. \

(54:33)

Does PCSK9 inhibition impact atherosclerosis? | Professor Steve Nicholls

(5:38)

EASL Studio – S3E9 – JHEP Live: ASOs vs siRNAs for treating chronic HBV: Who will be the winner?

(36:57)